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Abstract
Background: Maternal obesity has a wide range of health effects on both the pregnant woman and developing
fetus. The clinical significance of these disorders, combined with a dramatically increasing prevalence of obesity
among pregnant women has precipitated a major health crisis in the United States. The most commonly used
recommendations for gestational weight gain were established by the Institute of Medicine (IOM) in 2009 and have
become well known and often adopted. The authors of the IOM report acknowledged that the recommended
gestational weight gain of 5 to 9 kg for obese women whose body mass index was greater than 30 kg/m2 was
based on very little empirical evidence. The objective of this study was to evaluate whether a 5 to 9 kg weight gain,
for obese women, optimized a set of maternal and neonatal health outcomes.
Methods: Data containing approximately 12,000,000 birth records were obtained from the United States Natality
database for the years 2014 to 2016. A Bayesian modeling approach was used to estimate the controlled direct
effects of pre-pregnancy body mass index and gestational weight gain.
Results: Obese women gaining less than 5 kg during pregnancy had reduced maternal risks for gestational
hypertension, eclampsia, induction of labor and Caesarian section. In contrast, maternal gestational weight
gain of less than 5 kg was associated with increased risks for multiple adverse neonatal outcomes with
macrosomia the exception. Obese women who gained more than 9 kg during pregnancy had increased risk
for multiple maternal and neonatal adverse outcomes.
Conclusions: Obese women who were observed to gain less than 5 kg during gestation had reduced odds
of several peripartum disorders. However, this lower gestational weight gain was associated with an increase
in multiple risks for the neonate.
Keywords: Gestational weight gain, Body mass index, Neonatal, Maternal, Adverse outcomes

Background
Maternal obesity has a wide range of health effects on
both the pregnant woman and developing fetus [1, 2].
The clinical significance of these disorders, combined
with a dramatically increasing prevalence of obesity
among pregnant women has precipitated a major health
crisis in the United States [3]. Obesity during pregnancy
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is often attributed to the interplay of pre-pregnancy
obesity and gestational weight gain (GWG) and while
obesity established prior to pregnancy is a critical concern, it is not preventable when a pregnant woman first
seeks prenatal care. As a result of this limitation, addressing GWG becomes the primary preventative option
during prenatal care [4].
Maternal obesity causes pregnancy-onset metabolic
conditions including gestational diabetes mellitus
(GDM), gestational hypertension and pre-eclampsia/
eclampsia [5]. These prepartum conditions increase the
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risks for severe maternal morbidities (SMM) the unintended outcomes of the process of labor and delivery
that result in significant short-term or long-term consequences to a woman’s health [6]. Severe maternal morbidities include maternal blood transfusions, admission
to an Intensive Care Unit (ICU), ruptured uterus, unplanned hysterectomy and perineal lacerations. The list
of SMM also often includes caesarian section as a preferably prevented consequence of obesity. The neonatal
risks associated with maternal obesity, pre-partum metabolic conditions and SMM include mortality and with
multiple long term consequences [1, 7, 8].
In the United States, the most commonly used recommendations for GWG were established by the Institute
of Medicine (IOM) in 2009 [4]. Guidelines were developed for six categories of pre-pregnancy body mass
index (ppBMI) commonly used by the World Health
Organization (WHO). While publishing these guidelines,
the authors acknowledged a number of limitations including a lack of data to identify optimal GWG at higher
levels of obesity. As a result, the guidelines provided the
same recommendation for GWG of 5 to 9 kg for women
classified by the WHO BMI classifications as Obese I
(BMI of 30.00–34.99 kg/m2), Obese II (BMI of 35.00–
39.99 kg/m2) or Obese III (BMI of ≥40.00 kg/m2) [4]. To
resolve the deficiency of empirical evidence supporting
these guidelines, the IOM recommended collecting more
data and making these data available to researchers [4].
This recommendation has been followed. In the United
States, state laws require birth certificates to be completed for all births, and Federal law mandates national
collection and publication of births and other vital statistics data. The National Vital Statistics System, the
Federal compilation of this data, is the result of the cooperation between the National Center for Health Statistics and the states to provide access to statistical
information from birth certificates. The data collection
has included maternal metabolic conditions, SMM and
adverse neonatal outcomes. The relationships between
these and GWG can now be evaluated and, potentially,
updated on data-based criteria. Obesity related conditions that are recorded in the birth database include
pregnancy onset metabolic conditions, SMM and a variety of fetal viability assessments. The objective of this
study was to utilize the national vital statistics database
to evaluate whether a 5 to 9 kg weight gain, for obese
women, optimized a set of maternal and neonatal health
outcomes.

Methods
Data containing approximately 12,000,000 birth records
were obtained from the United States Natality database
for the years 2014 to 2016. The entire database was
downloaded and the following variables were extracted
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for analysis: maternal race/ethnicity, plurality, BMI class
and gestational weight gain. The BMI classification used
the six category WHO classification. The following maternal conditions and events were extracted: GDM, gestational hypertension, pre-eclampsia/eclampsia, occurrences
of labor induction and delivery by caesarian section, blood
transfusion, perineal laceration, uterine rupture, unplanned hysterectomy and ICU admission. The following
fetal conditions and events were extracted: birth weight,
obstetrical estimate of gestation length, five-minute Apgar
score, admission to NICU, whether the infant was ventilated for at least six minutes, and whether the baby was
alive at the time of the birth being recorded.
The maternal weight gain was standardized to 40
weeks of gestation using internal standardization. Gestational weight gain was then classified as being in the recommended range or above or below the range according
to the cut-points as recommended by IOM. For the purpose of classification, the following definitions were
used: Extremely low birth wieht (ELBW) was birth
weight less than 1000 g, very low birth weight (VLBW)
was birth at less than 1500 g, low birth weight (LBW)
was birth at less than 2500 g, very preterm birth (VPTB)
was birth before 32 weeks of gestation and preterm birth
(PTB) was birth before 37 weeks of gestation.
A Bayesian modeling approach was used to perform a
3-way decomposition of total effects into direct, indirect
and interactive effects [9, 10]. For each of i disorders,
case counts were cross-tabulated by j = 6 ppBMI classes
(underweight, normal weight, overweight and obese I,II
and III) and k = 3 GWG classes (less than recommended,
recommended and greater than recommended). For
each row in the table Yijk was the count of cases, at
birth, and nijk , the count of births. The counts, Yijk were
modeled as independent Binomial distributions conditional on an unknown rate parameter (μijk).


Yijk  Binomial μijk ; nijk
The logit of the rate parameter was then provided a
vague normal prior (Rijk) with a mean = 0 and variance =
100, for each combination of GWG and ppBMI.
 
Logit μijk ¼ Rijk
To aid in identifiability, the Rijk were then standardized to the stratum for which the estimate for the normal weight ppBMI with the observed recommended
weight gain was set to zero. The implementation used
Markov Chain Monte Carlo (MCMC) and the software
OpenBUGS 3.2.3 [11]. A burn-in of 5000 iterations was
allowed then the next 10,000 iterations were sampled for
the posterior distribution. Convergence was evaluated by
observing convergence of separate chains with diverse
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starting values. The median, the lower 2.5% limit, the median and the upper 97.5% limit were all drawn from the
complete posterior distributions. The authors refer to the
interval from the 2.5 percentile to 97.5 percentile values as
the 95% Bayesian credible interval. When the lower bound
of this credible interval is greater than 1, the value for the
Bayesian exceedance probability would be greater than
95% which would be relatively analogous to a frequentist
p-value of less than 5% for a 2-tailed test. The posterior
predictive p value was used to evaluate all odds ratios with
a p-value < 0.05 referred to as statistically significant [12].
Results were presented and discussed for obese women.
The model and data are provided for readers in additional
materials (Additional file 1).

Results
The database recorded 11,529,069 singleton births.
Incomplete records that were excluded numbered
568,351 that were missing ppBMI, 139,657 that were
missing maternal weight gain, 4385 that were missing gestation length estimates and 5171 that were
missing birth weights. The study modeled data from
10,811,496 birth records that were cross-stratified
into six ppBMI categories and three GWG categories
with the number and percent of each combination
among obese women reported in Table 1. These records included 2,716,860 women whose ppBMI was
classified as obese I, II or III.
The overall modeling was performed with the baseline
arbitrarily set at the combination of normal weight
ppBMI and the currently recommended GWG, for each
disorder. These model results are presented in Tables 2,
3 and 4. Table 2 presents the baseline incident risk as a
percent probability and Tables 3 and 4 as the odds ratios
for combinations of ppBMI and GWG with adverse
maternal outcomes and adverse neonatal outcomes,
respectively.
For women who were obese I, GWG less than 5 kg was
associated with a significantly decreased risk for gestational hypertension, induction of labor and Caesarian section and a significantly increased risk of gestational
diabetes. The neonates born to these women had
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Table 2 Baseline incidence risk (%) at normal pre-pregnancy
body mass index and recommended gestational weight gain
Disorder

Baseline incidence risk (%)

Maternal outcomes
Gestational diabetes

3.24 (3.21, 3.27)

Gestational hypertension

2.50 (2.48, 2.52)

Eclampsia

0.11 (0.11, 0.12)

Labor induction

14.6 (14.6, 14.7)

Caesarian section

15.3 (15.3, 15.4)

Maternal transfusion

0.24 (0.23, 0.24)

Perineal laceration

1.05 (1.03, 1.07)

Ruptured uterus

0.02 (0.02, 0.03)

Unplanned hysterectomy

0.03 (0.02, 0.03)

Admission to ICU

0.1 (0.1, 0.11)

Neonatal outcomes
Extremely low birth weight

0.22 (0.22, 0.23)

Very low birth weight

0.55 (0.54, 0.57)

Low birth weight

5.28 (5.25, 5.32)

Macrosomia

5.3 (5.26, 5.33)

Very pre-term birth

0.64 (0.63, 0.66)

Pre-term birth

5.76 (5.72, 5.8)

Low APGAR score

0.35 (0.34, 0.36)

Admission to neonatal ICU

5.71 (5.67, 5.74)

Ventilated for > 6 min

0.73 (0.71, 0.74)

Neonatal mortality

0.22 (0.21, 0.23)

significantly increased risk for extremely low birth weight,
very low birth weight, low birth weight, very preterm delivery, preterm delivery, low Apgar score, admission to
Neonatal Intensive Care Unit, ventilation for more than 6
min and neonatal mortality and a significantly reduced
risk for macrosomia. For women whose ppBMI was classified as Obese I, gaining more weight than 9 kg was associated with an increased risk for gestational hypertension,
eclampsia, induction of labor, Caesarian section and perineal laceration. The neonates born to these women had
increased risk for extremely low birth weight, macrosomia, very pre-term delivery, low Apgar score, admission to

Table 1 Cross stratification frequency table with counts of births and percent of births
Pre-pregnancy Body Mass Index
Underweight BMI < 18.5

Normal Weight BMI 18.5–24.9

Overweight
BMI 25.0–29.9

Obese I
BMI 30.0–34.9

Obese II
BMI 35.0–39.9

Obese III
BMI > 40.0

< Recommended

115,003
1.1%

1,216,654
11.3%

385,373
3.6%

238,594
2.2%

174,923
1.6%

163,436
1.5%

Recommended

158,559
1.5%

1,572,849
14.6%

621,887
5.8%

252,205
2.3%

136,807
1.3%

94,799
0.9%

> Recommended

123,477
1.1%

2,111,670
19.5%

1,789,164
16.6%

1,013,805
9.4%

408,098
3.8%

234,193
2.2%

Gestational weight gain
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Table 3 Model results (odds ratios) for maternal outcomes by category of pre-pregnancy body mass index and gestational weight
gain
Pre-pregnancy
body mass index

Obese I

Gestational weight
gain

< 5 kg

Gestational diabetes

3.5 (3.4, 3.5)a

Obese II

5–9 kg

a

> 9 kg

< 5 kg

Obese III

5–9 kg

> 9 kg

< 5 kg

5–9 kg

> 9 kg

3.3 (3.3, 3.4)

a

2.5 (2.5, 2.5)

a

4.3 (4.2, 4.3)

a

4.0 (3.9, 4.0)

a

3.3 (3.2, 3.3)

a

5.3 (5.2, 5.4)

a

4.7 (4.6, 4.8)

a

4.3 (4.2, 4.4)

a

2.5 (2.5, 2.6)

a

3.8 (3.8, 3.9)

a

3.0 (2.9, 3.0)

a

3.6 (3.6, 3.7)

a

5.3 (5.2, 5.3)

a

4.5 (4.4, 4.5)

a

5.4 (5.3, 5.5)

a

7.3 (7.2, 7.4)

a

Gestational
hypertension

2.1 (2, 2.1)

Eclampsia

2.0 (1.8, 2.2)

a

2.1 (1.9, 2.3)

a

3.4 (3.2, 3.6)

a

2.5 (2.3, 2.8)

a

2.9 (2.6, 3.2)

a

4.6 (4.3, 4.9)

a

3.5 (3.2, 3.9)

a

4.6 (4.1, 5.0)

a

6.1 (5.7, 6.5)

a

Labor induction

1.2 (1.2, 1.2)

a

1.3 (1.3, 1.3)

a

1.4 (1.4, 1.4)

a

1.4 (1.4, 1.4)

a

1.5 (1.5, 1.5)

a

1.5 (1.5, 1.5)

a

1.6 (1.6, 1.6)

a

1.6 (1.5, 1.6)

a

1.6 (1.6, 1.6)

a

1.5 (1.5, 1.5)

a

1.7 (1.7, 1.7)

a

2.0 (2.0, 2.0)

a

1.9 (1.8, 1.9)

a

2.1 (2.1, 2.1)

a

2.6 (2.5, 2.6)

a

2.6 (2.6, 2.7)

a

2.9 (2.9, 3.0)

a

3.4 (3.4, 3.4)

a

Maternal transfusion

1.3 (1.2, 1.4)

a

1.2 (1.1, 1.3)

a

1.2 (1.1, 1.2)

a

1.2 (1.1, 1.4)

a

1.1 (1.0, 1.3)

a

1.2 (1.1, 1.3)

a

1.3 (1.2, 1.4)

a

1.2 (1.1, 1.4)

a

1.3 (1.2, 1.5)

a

Perineal laceration

0.5 (0.4, 0.5)

b

0.5 (0.5, 0.5)

b

0.6 (0.5, 0.6)

b

0.4 (0.4, 0.4)

b

0.4 (0.4, 0.4)

b

0.4 (0.4, 0.5)

b

0.3 (0.3, 0.3)

b

0.3 (0.3, 0.4)

b

0.3 (0.3, 0.3)

b

1.4 (1.1, 1.8)

a

1.3 (0.9, 1.9)

Unplanned
hysterectomy

1.8 (1.4, 2.1)

a

Admission to ICU

1.4 (1.2, 1.5)

Caesarian section

Ruptured uterus

a
b

1.3 (1.1, 1.5)

a

1.4 (1.1, 1.8)

a

1.7 (1.4, 2.1)

a

1.5 (1.3, 1.8)

a

1.5 (1.1, 1.9)

a

1.3 (1.1, 1.4)

a

1.3 (1.3, 1.4)

a

1.5 (1.3, 1.7)

a

1.1 (0.9, 1.5)

1.2 (1.0, 1.5)

a

1.6 (1.2, 2.1)

a

1.3 (1.0, 1.7)

a

1.6 (1.3, 1.9)

a

1.9 (1.5, 2.3)

a

1.3 (1.1, 1.5)

a

1.5 (1.4, 1.7)

a

1.7 (1.5, 2.0)

a

1.1 (0.8, 1.5)

1.4 (1.1, 1.8)

a

1.7 (1.3, 2.3)

a

1.9 (1.5, 2.3)

a

1.6 (1.4, 1.9)

a

2.6 (2.4, 2.9)

a

Odds ratio is significantly elevated relative to ideal BMI and recommended weight gain
Odds ratio is significantly lower relative to ideal BMI and recommended weight gain

Neonatal Intensive Care Unit and ventilation for more
than 6 min and significantly reduced risk for low birth
weight and preterm delivery (Table 5).
Gaining less than 5 kg, for obese II women was associated with a significantly decreased risk for gestational
hypertension, eclampsia, induction of labor and Caesarian section and a significantly increased risk of gestational diabetes. The neonates born to these women had
increased risk for extremely low birth weight, very low
birth weight, low birth weight, very preterm delivery,
preterm delivery, low Apgar score, ventilation for more
than 6 min and neonatal mortality and a significantly

reduced risk for macrosomia. For women whose ppBMI
was classified as obese II, gaining more weight than 9 kg
was associated with a significantly decreased risk of gestational diabetes and a significantly increased risk for
gestational hypertension, eclampsia, induction of labor,
Caesarian section, perineal laceration and admission to
Intensive Care Unit. The neonates born to these women
had increased risk for extremely low birth weight, very
low birth weight, macrosomia, very pre-term delivery,
preterm delivery, low Apgar score, admission to Neonatal Intensive Care Unit, ventilation for more than 6
min and neonatal mortality (Table 6).

Table 4 Model results (odds ratios) for neonatal outcomes by category of pre-pregnancy body mass index and gestational weight
gain (GWG)
Pre-pregnancy
body mass index

Obese I

Obese II

Gestational weight
gain

< 5 kg

Extremely low birth
weight

4.4 (4.2, 4.6)

a

2.4 (2.2, 2.5)

a

2.5 (2.4, 2.6)

Very low birth weight

3.2 (3.1, 3.3)

a

2.0 (1.9, 2.1)

a

2.1 (2, 2.1)

1.6 (1.5, 1.6)

a

1.2 (1.2, 1.3)

a

1.0 (1.0, 1.1)

a

Macrosomia

1.1 (1.1, 1.1)

a

1.5 (1.5, 1.5)

a

2.6 (2.5, 2.6)

a

Very pre-term birth

3.0 (2.9, 3.1)

a

1.9 (1.8, 2.0)

a

2.0 (1.9, 2.0)

a

1.6 (1.6, 1.7)

a

1.5 (1.5, 1.5)

a

1.5 (1.4, 1.5)

a

2.2 (2.1, 2.3)

a

1.6 (1.5, 1.7)

a

1.7 (1.6, 1.8)

a

Admission to neonatal
ICU

1.4 (1.4, 1.5)

a

1.3 (1.3, 1.4)

a

1.5 (1.5, 1.5)

a

Ventilated for > 6 min

1.8 (1.7, 1.9)

a

1.4 (1.3, 1.5)

a

1.7 (1.6, 1.7)

a

2.5 (2.3, 2.7)

a

1.6 (1.5, 1.7)

a

1.6 (1.5, 1.6)

a

Low birth weight

Pre-term birth
Low APGAR score

Neonatal mortality
a

5–9 kg

> 9 kg

< 5 kg
a

a

Obese III

5–9 kg

> 9 kg

< 5 kg

5–9 kg

> 9 kg

4.3 (4.1, 4.6)

a

2.6 (2.4, 2.8)

a

3.2 (3.1, 3.4) a

4.5 (4.2, 4.7)

a

2.8 (2.6, 3.1)

a

4.0 (3.8, 4.3)

a

3.1 (2.9, 3.2)

a

2.1 (2.0, 2.2)

a

2.6 (2.5, 2.7) a

3.2 (3.1, 3.4)

a

2.3 (2.2, 2.5)

a

3.2 (3.1, 3.3)

a

1.4 (1.4, 1.4)

a

1.1 (1.1, 1.2)

a

1.1 (1.1, 1.2)

a

1.3 (1.3, 1.4)

a

1.2 (1.2, 1.2)

a

1.3 (1.3, 1.3)

a

1.5 (1.5, 1.5)

a

2.0 (2.0, 2.0)

a

3.1 (3.1, 3.1)

a

1.9 (1.9, 2.0)

a

2.6 (2.5, 2.6)

a

3.6 (3.6, 3.6)

a

2.9 (2.8, 3.0)

a

2.0 (1.9, 2.1)

a

2.4 (2.3, 2.5) a

3.0 (2.9, 3.1)

a

2.2 (2.0, 2.3)

a

3.0 (2.9, 3.1)

a

1.6 (1.6, 1.6)

a

1.6 (1.5, 1.6)

a

1.7 (1.7, 1.7)

a

1.7 (1.7, 1.8)

a

1.7 (1.7, 1.8)

a

2.0 (2.0, 2.1)

a

2.3 (2.2, 2.5)

a

1.6 (1.5, 1.8)

a

2.1 (2.0, 2.2)

a

2.5 (2.4, 2.7)

a

2.2 (2.0, 2.4)

a

2.8 (2.7, 3.0)

a

1.4 (1.4, 1.5)

a

1.4 (1.4, 1.5)

a

1.7 (1.7, 1.7)

a

1.6 (1.6, 1.7)

a

1.7 (1.7, 1.8)

a

2.1 (2.1, 2.2)

a

1.9 (1.8, 2.0)

a

1.7 (1.6, 1.8)

a

2.0 (1.9, 2.1) a

2.2 (2.1, 2.3)

a

2.2 (2.1, 2.3)

a

2.7 (2.6, 2.8)

a

2.4 (2.2, 2.6)

a

1.6 (1.4, 1.7)

a

a

2.5 (2.3, 2.7)

a

1.9 (1.7, 2.1)

a

a

Odds ratio is significantly elevated relative to ideal BMI and recommended weight gain

1.8 (1.7, 1.9)

2.2 (2, 2.3)
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Table 5 Odds ratios for women classified as obese I. Odds ratios are for the class of gestational weight gain (less than 5 kg and
more than 9 kg) relative to 5 to 9 kg
Gestational Weight Gain < 5.0 kg

Gestational Weight Gain > 9.0 kg

Gestational diabetes

1.04 (1.02, 1.06) a

0.76 (0.75, 0.77) b

Gestational hypertension

0.82 (0.80, 0.84)b

1.52 (1.49, 1.55) a

Eclampsia

0.93 (0.83, 1.04)

1.59 (1.46, 1.73) a

Induction of labor

0.97 (0.96, 0.99) b

1.09 (1.08, 1.11) a

Caesarian Section

b

1.21 (1.20, 1.22) a

Maternal Conditions

0.88 (0.87, 0.90)

Maternal transfusion

1.08 (0.98, 1.20)

1.02 (0.94, 1.11)

Perineal laceration

0.98 (0.90, 1.05)

1.16 (1.09, 1.23) a

Ruptured uterus

1.24 (0.89, 1.71)

1.12 (0.87, 1.47)

Unplanned hysterectomy

1.01 (0.78, 1.30)

0.89 (0.73, 1.10)

Admission to Intensive Care Unit

1.07 (0.92, 1.25)

1.07 (0.94, 1.20)

Neonatal Conditions
Extremely low birth weight

1.87 (1.74, 2.00) a

1.07 (1.01, 1.14) a

1.58 (1.51, 1.66)

a

1.02 (0.98, 1.07)

1.27 (1.24, 1.29)

a

0.84 (0.83, 0.86) b

Macrosomia

0.73 (0.71, 0.74)

b

1.72 (1.69, 1.75) a

Very pre-term delivery

1.61 (1.54, 1.69) a

1.06 (1.02, 1.10) a

Preterm delivery

1.10 (1.08, 1.12)

a

0.96 (0.95, 0.98) b

Low Apgar score

1.40 (1.31, 1.05) a

1.07 (1.01, 1.13) a

Admission to Neonatal Intensive Care Unit

1.07 (1.05, 1.09)

a

1.09 (1.08, 1.11) a

Ventilation for more than 6 min

1.27 (1.21, 1.34) a

1.18 (1.13, 1.23) a

Very low birth weight
Low birth weight

Neonatal mortality

1.56 (1.43, 1.70)

a

0.97 (0.91, 1.05)

a

Odds ratio is significantly elevated relative to gestational weight gain of 5 to 9 kg
b
Odds ratio is significantly lower relative to gestational weight gain of 5 to 9 kg

For women whose ppBMI was classified as obese III,
gaining less weight, during gestation, than 5 kg was associated with a significantly decreased risk for gestational
hypertension, eclampsia and Caesarian section and a significantly increased risk of gestational diabetes and induction of labor. The children born to these women had
increased risk for extremely low birth weight, very low
birth weight, low birth weight, very pre-term delivery,
low Apgar score and neonatal mortality and significantly
reduced risk for macrosomia and admission to Neonatal
Intensive Care Unit. For women whose ppBMI was classified as obese III, gaining more than 9 kg was associated
with a significantly decreased risk of gestational diabetes
and significantly increased risk of gestational hypertension, eclampsia, induction of labor, Caesarian section
and admission to Intensive Care Unit. The neonates
born to these women had increased risk for extremely
low birth weight, very low birth weight, low birth weight,
macrosomia, very pre-term delivery, preterm delivery,
low Apgar score, admission to Neonatal Intensive Care
Unit, ventilation for more than 6 min and neonatal mortality (Table 7).

Discussion
The interaction model implemented in this study is
fundamentally similar to employing stratification for
confounding control. In causal modeling the estimates
can be referred to as the CDE or conditional direct
effects because they are estimated at specific levels of
the modifying variable(s) [13, 14]. This approach was
modified by VanderWeele [9, 15] such that the
CDE(s) can be estimated using an interaction model.
An interaction model equivalent to the VanderWeele
approach is readily implemented under an MCMC
Bayesian modeling approach using commonly available statistical software. [11] One distinction is that
the inferences derived from the analyses reported here
are individual-based and not population-based and
are appropriate for a clinician to report to a patient,
that patient’s risk. The model provided in the appendix can be modified to estimate the improvement in
individual risk and its confidence bounds for a patient
prior to becoming pregnant and allowing for modification of both ppBMI and planning on a specific
GWG.
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Table 6 Odds ratios for women classified as obese II. Odds ratios are for the class of gestational weight gain (less than 5 kg and
more than 9 kg) relative to 5 to 9 kg
Gestational Weight Gain < 5.0 kg

Gestational Weight Gain > 9.0 kg

Gestational diabetes

1.08 (1.06, 1.10) a

0.83 (0.81, 0.84) b

Gestational hypertension

0.81 (0.79, 0.83) b

1.44 (1.41, 1.47) a

Eclampsia

0.88 (0.77, 1.00)

b

1.61 (1.45, 1.79) a

Induction of labor

0.99 (0.97, 1.00) b

1.05 (1.03, 1.06) a

Caesarian Section

0.88 (0.87, 0.90)

b

1.22 (1.20, 1.23) a

Maternal transfusion

1.09 (0.96, 1.25)

1.05 (0.94, 1.19)

Perineal laceration

1.01 (0.91, 1.13)

1.13 (1.03, 1.25) a

Maternal Conditions

Ruptured uterus

1.27 (0.84, 1.98)

1.11 (0.77, 1.63)

Unplanned hysterectomy

1.12 (0.78, 1.62)

1.22 (0.90, 1.69)

Admission to Intensive Care Unit

1.14 (0.94, 1.37)

1.17 (1.00, 1.38) a

Neonatal Conditions
Extremely low birth weight

b

1.26 (1.16, 1.36) a

a

1.21 (1.15, 1.28) a

Very low birth weight

1.45 (1.36, 1.54)

Low birth weight

1.22 (1.19, 1.26) a

0.99 (0.97, 1.02)

Macrosomia

0.75 (0.73, 0.77) b

1.55 (1.52, 1.58) a

Very pre-term delivery

1.46 (1.38, 1.55) a

1.21 (1.15, 1.28) a

Preterm delivery

1.03 (1.01, 1.06)

a

1.08 (1.05, 1.10) a

Low Apgar score

1.44 (1.31, 1.57) a

1.28 (1.18, 1.39) a

Admission to Neonatal Intensive Care Unit

1.00 (0.97, 1.03)

1.19 (1.16, 1.21) a

Ventilation for more than 6 min

1.10 (1.04, 1.17) a

1.16 (1.09, 1.22) a

a

1.13 (1.02, 1.25) a

Neonatal mortality
a

1.68 (1.55, 1.84) a

1.51 (1.35, 1.69)

Odds ratio is significantly elevated relative to gestational weight gain of 5 to 9 kg
Odds ratio is significantly lower relative to gestational weight gain of 5 to 9 kg

The current study supports previous studies that have
shown maternal health benefits for obese pregnant
women who gain less weight than 5 kg or even lose
weight [16–18]. Specifically, odds for gestational hypertension, eclampsia, induction of labor and Caesarian
section were reduced by the lower GWG. This was consistent across ppBMI. In contrast to the analyses of maternal outcomes, the analysis of adverse neonatal
outcomes does not support gestational weight gains that
are less than 5 kg. Much of the literature addressing fetal
or neonatal risks is based on birth weights and gestational length and, collectively, the findings are inconsistent [19–21]. The current study reports substantial risks
for both underweight and preterm births and the odds
for neonatal mortality are elevated 50%. These risks are
substantial and the evidence should discourage any lowering of the 5 kg lower limit of the IOM guidelines.
However, the recommendation by ACOG to monitor
fetal growth and development when an obese woman is
trying to lose weight or gain less than 5 kg [22] is supported by the current findings. A demonstration that
monitoring fetal growth can also identify the fetuses at
risk of neonatal mortality caused by too low gestation

weight gain would further strengthen the ACOG recommendation. More research into more specific nutritional
advice for women who want to lose weight and simultaneously support appropriate fetal development should
be encouraged.
The current study showed that, it is harmful for both
the mother and neonate for obese women to gain more
than 9 kg, during gestation. With few exceptions, adverse
maternal outcomes occurred with greater odds when the
limit was exceeded. The exception that was consistent
for all ppBMI classes was GDM that occurred with decreased odds at the higher class of GWG. Analyses of
adverse neonatal outcomes provided considerable additional support for obese women to gain less than 9 kg,
during gestation. With few exceptions, adverse neonatal
outcomes occurred with greater odds when the limit
was exceeded. The exception was low birth weight and
PTD had a significantly sparing effect among obese III
women who gained more than 9 kg.
Current results showed that GWG was lower
among women who developed GDM but the causal
relationship remains obscure. Both steps in lowering
GWG from above recommended to recommended
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Table 7 Odds ratios for women classified as obese III. Odds ratios are for the class of gestational weight gain (less than 5 kg and
more than 9 kg) relative to 5 to 9 kg
Gestational Weight Gain < 5.0 kg

Gestational Weight Gain > 9.0 kg

Gestational diabetes

1.13 (1.10, 1.15)a

0.91 (0.89, 0.93) b

Gestational hypertension

0.82 (0.80, 0.84) b

1.35 (1.32, 1.38) a

Eclampsia

0.77 (0.69, 0.87)

b

1.33 (1.20, 1.47) a

Induction of labor

1.02 (1.00, 1.04) a

1.01 (1.00, 1.03) a

Caesarian Section

0.90 (0.89, 0.92)

b

1.17 (1.15, 1.19) a

Maternal transfusion

1.10 (0.94, 1.27)

1.12 (0.98, 1.29)

Perineal laceration

0.90 (0.79, 1.03)

0.94 (0.83, 1.07)

Maternal Conditions

Ruptured uterus

1.21 (0.79, 1.92)

1.06 (0.70, 1.63)

Unplanned hysterectomy

1.07 (0.75, 1.55)

1.07 (0.76, 1.52)

Admission to Intensive Care Unit

1.06 (0.87, 1.29)

1.58 (1.33, 1.89) a

Neonatal Conditions
Extremely low birth weight

1.59 (1.45, 1.74) a

1.43 (1.31, 1.57) a

a

1.36 (1.28, 1.45) a

Very low birth weight

1.38 (1.29, 1.48)

Low birth weight

1.13 (1.09, 1.17)a

1.09 (1.06, 1.12) a

Macrosomia

0.75 (0.73, 0.76)

b

1.39 (1.36, 1.43) a

Very pre-term delivery

1.41 (1.32, 1.50) a

1.38 (1.30, 1.47) a

Preterm delivery

0.99 (0.96, 1.02)

1.17 (1.14, 1.20) a

Low Apgar score

1.15 (1.05, 1.25) a

1.29 (1.18, 1.40) a

b

1.23 (1.20, 1.27) a

Admission to Neonatal Intensive Care Unit

0.94 (0.92, 0.97)

Ventilation for more than 6 min

1.03 (0.96, 1.10)

Neonatal mortality

1.30 (1.15, 1.46)

1.24 (1.17, 1.31) a
a

1.15 (1.02, 1.28) a

a

Odds ratio is significantly elevated relative to gestational weight gain of 5 to 9 kg
Odds ratio is significantly lower relative to gestational weight gain of 5 to 9 kg

b

and from recommended to less that recommended
GWG were associated with increased rates of GDM.
If the relationship was causal, the conclusion would
be that higher GWG prevented GDM. However, the
authors of the IOM guidelines predicted difficulties
identifying the causal ordering between GWG and
disorders that develop during pregnancy, like GDM,
and also advised that conditions diagnosed early in
pregnancy and managed effectively, may have reduced
risk. As predicted, studies evaluating the effect of
GWG on GDM has been shown risks to be both increased [23] and decreased [24] The Committee also
accurately predicted that treatment for the condition
would alter the pattern of weight gain after diagnosis
[25, 26]. More recent studies have evaluated GWG
prior to early screening and shown that early in pregnancy, increased GWG does precede the diagnosis of
GWG [27–29].
This study is limited by the observational nature of
the data. The interaction model implemented in this
study only corrects for confounding by variables included in the model not for confounding by unrecorded
or omitted variables. The current results on GWG on

adverse outcomes are not confounded by ppBMI but
may be confounded by treatment variables. More specific causal inferences should be pursued. For example,
more specific causal modeling could address how
ppBMI and GWG contribute to GDM and adverse
effects by GDM causing complicating causes that are
certain to include hypertension, eclampsia and macrosomia. Further research could clarify the mediating
effect of GDM on the relationships between the components of maternal obesity and adverse outcomes
through additional causal factors like hypertension and
eclampsia. To this end, the modeling approach implemented in this study can be expanded to include analyses specific to two groups of women, including those
who do and those who do not develop GDM. This
could be achieved by modeling all possible 3-way interactions among ppBMI, GWG and GDM. When
combined with close monitoring for the chance development of GDM, the clinician can be equipped with
the most useful nutritional recommendations related to
GWG. We anticipate that the recommendations for
GWG will vary with both ppBMI and GDM diagnosis
and we encourage further research.
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Conclusions
Obese women who were observed to gain less than 5 kg
during gestation had reduced odds of several peripartum
disorders. However, this lower gestational weight gain was
associated with an increase in multiple risks for the neonate.
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